Topical antibacterial medications for therapy of patient with acne

Cover Page


Cite item

Full Text

Abstract

Problems of acne pathogenesis are reviewed. Efficacy evaluation and safety use of 1% clindamycin solution at patient with acne are demonstrated.

About the authors

A. G. Pashinjan

The Russian National Research Medical University named after N.I. Pirogov

Author for correspondence.
Email: stsoagp@gmail.com
Россия

A. A. Shahnovich

FGBU “Polyclinic № 5” Office of the President of the Russian Federation

Email: stsoagp@gmail.com
Россия

References

  1. Dreno B. Recent data on epidemiology of acne. Ann Dermatol Venereol 2010; 137(2): 49-51. doi: 10.1016/S0151-9638(10)70024-7.
  2. Bhate K., Williams H.C. Epidemiology of acne vulgaris. Br J Dermatol 2013; 168(3): 474- 485. doi: 10.1111/bjd.12149.
  3. Dreno B., Layton A., Zouboulis C.C., Lopez-Estebaranz J.L., Zalewska-Janowska A., Bagat in E. et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013; 27: 1063-70. doi: 10.1111/jdv.12061.
  4. Ghodsi S.Z., Orawa H., Zouboulis C.C. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009; 129(9): 2136- 2141. doi: 10.1038/jid.2009.47.
  5. Makrantonaki E., Ganceviciene R., Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3(1): 41-49. doi:10.4161.
  6. Kircik L.H. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15(1): 7-10.
  7. Arora M.K., Yadav A., Saini V. Role of hormones in acne vulgaris. Clin Biochem. 2011; 44(13): 1035-40. doi: 10.1016.
  8. Cunha M.G., Fonseca FLA, Machado CDAS. Androgenic Hormone Profile of Adult Women with Acne. Dermatology 2013; 226(2): 167-71. doi: 10.1159/000347196.
  9. Schmidt T.H., Shinkai K. Evidence-based approach to cutaneous hyperandrogenism in women. J Am Acad Dermatol 2015; 73(4): 672-90. doi: 10.1016.
  10. Del Prete M., Mauriello M.C., Faggiano A., Di Somma C., Monfrecola G., Fabbrocini G., Co-lao A. Insulin resistance and acne: a new risk factor for men? Endocrine 2012; 42: 555-60. doi: 10.1007/s12020-012-9647-6.
  11. Pace J.L. Acne - a potential skin marker of internal disease. Clin Dermatol 2015; 33(5): 572-8. doi: 10.1016/j.clindermatol.2015.05.010.
  12. Perry A., Lambert P. Propionibacterium acnes: Infection beyond the skin. Expert Review of Anti-infective Therapy 2011; 9 (12): 1149-56. doi: 10.1586/eri.11.137.
  13. Gomes PdeS., Fernandes M.H. Defensins in the oral cavity: distribution and biological role. J Oral Pathol Med 2010; 39(1): 1-9. doi: 10.1111/j.1600-0714.2009.00832.
  14. Niyonsaba F., Nagaoka I., Ogawa H., Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit. Rev. Immunol 2006; 26(6): 545-76.
  15. Ozlu E., Karadag A.S., Ozkanli S., Oguztuzun S., Kilic M., Zemheri E et al. Comparison of TLR-2, TLR-4, and antimicrobial peptide levels in different lesions of acne vulgaris. Cutan Ocul Toxicol 2015; (23):1-10. doi: 10.3109/15569527.2015.1120742.
  16. Kim M.K., Choi S.Y., Byun H.J., Huh C.H., Park K.C., Patel R.A. et al. Comparison of sebum secretion, skin type, pH in humans with and without acne. Arch Dermatol 2006; 298(3):113-9.
  17. Schauber J., Gallo R.L. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J Invest Dermatol 2007; 127(3): 510-2.
  18. Pashinyan A.G. Modern methods of therapy of an acne. Medical Council 2010;(5-6): 61-62 [Пашинян А.Г. Современные методы терапии акне. Медицинский Совет 2010; (5-6): 61-62].
  19. Zaenglein A.L., Pathy A.L., Schlosser B.J., Alikhan A., Baldwin H.E., Berson D.S. et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74(5): 945-73. doi: 10.1016/j.jaad.2015.12.037.
  20. Savage L.J., Layton A.M. Treating acne vulgaris: systemic, local and combination therapy. Expert Rev Clin Pharmacol 2010; 13: 563- 580. doi: 10.1586/ecp.10.27.
  21. Kubanova A.A., Kubanov A.A., Samzov V.A., Araviiskaia E.A. Federalnyie klinicheskie rekomendatsii po vedeniyu bolnyih akne. Rossiyskoe obschestvo dermatovenerologov i kosmetologov. M., 2016; 9-27. [Кубанова А.А., Кубанов А.А., Самцов А.В., Аравийская Е.Р. Федеральные клинические рекомендации по ведению больных акне. Российское общество дерматовенерологов и косметологов. М., 2016; 9-27].
  22. Kanliff V.Dzh. Akne. V kn: Katsambas A. D., Lotti T. M. (red.) Evropeyskoye rukovodstvo po lecheniyu dermatologicheskikh zabolevaniy: Per. s angl. M.: MEDpress-inform. 2008; 19-24. [Канлифф В.Дж. Акне. В кн: Кацамбас А. Д., Лотти Т. М. (ред.) Европейское руководство по лечению дерматологических заболеваний: Пер. с англ. М: МЕДпресс-информ, 2008; 19-24.]
  23. Del Rosso J.Q., Schmidt N.F. A review of the antiinflammatory properties of clindamycin in the treatment of acne vulgaris. Cutis. 2010; 85(1):15-24.
  24. Alirezai M., Gerlach B., Horvath A., Forsea D., Bri-antais P., Guyomar M. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris. Eur J Dermatol 2005; 15(4): 274-8.
  25. Guay D.R. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmaco-ther 2007; 8(15): 2625-64.
  26. Monakhov S.A. Clindamycinsolution (1%) in thetherapy of acne. Klin Dermatol Venerol 2012; (5): 85-88 [Монахов С.А. Раствор клиндамицина (1%) в терапии акне. Клин дерматол и венерол 2012; (5): 85-88].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Pashinjan A.G., Shahnovich A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies